Stockscreener 앱 받기
322.81
0.31%
1.01
시간 외 거래:
322.81
전일 마감가:
$321.80
열려 있는:
$323.97
하루 거래량:
1.31M
Relative Volume:
1.49
시가총액:
$22.81B
수익:
$3.22B
순이익/손실:
$542.70M
주가수익비율:
43.15
EPS:
7.4805
순현금흐름:
$458.00M
1주 성능:
+2.02%
1개월 성능:
+9.29%
6개월 성능:
+16.43%
1년 성능:
+53.38%
1일 변동 폭
$319.06
$324.35
1주일 범위
$308.23
$324.35
52주 변동 폭
$206.10
$330.88
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
322.81 | 22.73B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
424.64 | 150.03B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.12 | 40.89B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.29 | 32.02B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.56 | 31.12B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
190.57 | 29.51B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's what to expect from West Pharmaceutical's next earnings report - MSN
Is Wall Street bullish or bearish on West Pharmaceutical Services stock? - MSN
Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating - Moomoo
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now - TradingView
Is Wall Street Bullish or Bearish on West Pharmaceutical Services Stock? - Yahoo Finance
A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum - Yahoo Finance
West Pharmaceutical Services, Inc. (WST) Stock Analysis: A Healthcare Giant with Notable Growth Potential - DirectorsTalk Interviews
WST Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
West Pharma fully restores operations after cyber attack - MSN
West Pharmaceutical Services (NYSE:WST) Shows Explosive Potential with Perfect Minervini Trend Template and Accelerating Growth - ChartMill
West Pharmaceutical Services Gains Spotlight In S&P 500 Momentum - Kalkine Media
Q1 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), Centene (CNC) - The Globe and Mail
West Pharmaceutical restores operations after cyberattack - Plastics News
Analysts Are Bullish on Top Healthcare Stocks: EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:EBR), West Pharmaceutical Services (WST) - The Globe and Mail
West Pharmaceutical Services (WST) Stock Price, News & Analysis $WST - MarketBeat
A Look at West Pharmaceutical Services Inc (WST) After 3.5% Gain -- GF Value $359.79 vs Price $316.13 - GuruFocus
West Pharmaceutical Shares Rise After Update on Restoration of Core Enterprise Systems Following Cyberattack - Moomoo
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - TradingView
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Zacks Investment Research
West Pharma says fully operational after cyberattack, sees no hit to 2026 forecast - 104.1 WIKY
Cyber incident update: West Pharmaceutical (NYSE: WST) restores operations - Stock Titan
WST Stock Price, Quote & Chart | WEST PHARMACEUTICAL SERVICES (NYSE:WST) - ChartMill
Trump's Stock Picks Perfectly Timed With New Medicare Rules: ReportEli Lilly (NYSE:LLY) - Benzinga
West Pharma drops after cyber attack - MSN
Trump bought stock in drugmaker as his government boosted its obesity drugs - Fierce Pharma
S&P 500 gains and losses today: West Pharmaceutical Services stock surges; Dow, LKQ shares fall - MSN
West Declares Quarterly Dividend - Quantisnow
Ransomware Attacks on West Pharmaceutical and Foxconn Highlight Growing Cyber Risks to Manufacturing Sector - Homeland Security Today
Zacks Research Analysts Raise Earnings Estimates for WST - MarketBeat
West Pharmaceutical (WST) Provides Cyberattack Recovery Update - GuruFocus
West Pharmaceutical Services ramps production following cyberattack - Investing.com
West Pharmaceutical says making progress in restoring global operations after cyberattack - marketscreener.com
West Pharma says operations recovering after cyberattack - WSAU
West Pharmaceutical Services ramps production following cyberattack By Investing.com - Investing.com Canada
West Pharmaceutical Services Inc recently announced that the company has continued to make significant progress in restoring operations after responding to a global cyberattack incident. - Bitget
Apprenticeship Week highlights ‘earn-while-you-learn’ approach - The Pennsylvania State University
West Pharmaceutical Services Inc announced that its High Value Product (HVP) sites, standard packaging sites, and HVP delivery device sites have now fully resumed shipping and receiving operations. - Bitget
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now - TradingView
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care - TradingView
Coated Butyl Rubber Stopper Market is Expanding Globally | Major - openPR.com
West Pharmaceutical Services (NYSE:WST) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Cyberattack On West Pharmaceutical Halts Manufacturing Across Multiple Sites - Information Security Buzz
West Pharmaceutical Cyberattack Tests Operational Resilience And Investor Risk Assumptions - Sahm
[Form 4] WEST PHARMACEUTICAL SERVICES INC Insider Trading Activity - Stock Titan
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay - TradingView
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.32%
0.96%
자본화:
|
볼륨(24시간):